My Cart

Human PAR1 Full Length Protein, Flag,His Tag (Detergent)

Customer Reviews
Cat. No. / Size
Price
Qty
PA1-H52D3-20ug
$805.00
PA1-H52D3-100ug
$2985.00
PA1-H52D3-500ug
$7480.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Application

    1. Immunization
    2. Affinity testing (SPR / BLI)
    3. Screening (ELISA)
  • Synonyms

    F2R, coagulation factor II thrombin receptor, CF2R, HTR, PAR-1, PAR1, TR

  • Source

    Detergent Human PAR1 Full Length Protein, Flag,His Tag (PA1-H52D3) is expressed from human 293 cells (HEK293). It contains AA Ser 42 - Ser 395 (Accession # P25116-1).

    Predicted N-terminus: Asp

    Request for sequence
  • Molecular Characterization

    PAR1 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a flag tag at the N-terminus and a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 58.7 kDa. The protein migrates as 55-180 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

    *The DDM/CHS buffer (Cat. No. DC-11) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Each full-length transmembrane protein is encapsulated by detergent micelle.

    2. Synthesis Process

      Through mild detergent micelle extraction, dedicated solubilization, and stringent affinity purification, we maximally retain the native transmembrane conformation of full-length transmembrane proteins throughout downstream purification. This workflow yields purified, detergent-solubilized proteins free of unrelated membrane impurities and exogenous scaffold proteins, with exceptional purity, accurate quantitation, and well-preserved biological activity—ideal for immunization, binding assays in antibody discovery and screening (ELISA) and affinity testing (SPR and BLI), etc.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    This product is not suitable for cell based experiments due to cytotoxicity of DDM.
    DDM and CHS are INDISPENSABLE to keep membrane protein soluble and active, under no circumstances should you remove DDM and CHS.
    DDM/CHS buffer (DC-11) is sold separately and not included in protein, and please contact us if you need the buffer.
    If glycerol is not compatible with your application, remove glycerol just before the immediate experiment, and NEVER store glycerol-free protein solution.

    Supplied as 0.2 μm filtered solution in 50 mM HEPES, 150 mM Nacl, DDM, CHS, pH7.5 with glycerol as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 12 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    PAR1 SDS-PAGE

    Human PAR1 Full Length Protein, Flag,His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • Bioactivity-ELISA

     PAR1 ELISA

    Immobilized Human PAR1 Full Length Protein, Flag,His Tag (Cat. No. PA1-H52D3) at 1 μg/mL (100 μL/well) can bind PAR1 Monoclonal Antibody with a linear range of 0.2-5 ng/mL (QC tested).

    Protocol

Customer Reviews
Writing Reviews

Background

PAR1, or Protease-Activated Receptor 1, is a key protein on cell surfaces that responds to thrombin, an enzyme involved in blood clotting. When activated, PAR1 triggers critical cellular responses, including platelet aggregation and inflammation. It plays a vital role in hemostasis and thrombosis, making it an important target for antiplatelet therapies.

Recent Advances

 
Drug Development Progress
  • English Name:

    Protease-activated receptor-1

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    3 Details

  • Highest Development Stage:

    Phase 1 Clinical

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland